Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cardio Diagnostics Holdings, Inc.

NASDAQ: CDIO · Life Sciences · 2 alerts · CIK 1870144

Share price
$1.79Close, Nov 16
Market cap
$5.3M
Shares outstanding
2.96MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cardio Diagnostics Holdings, Inc. filings on SEC EDGAR ↗

8:01 AM ET 10-Q
Financial Results

Cardio Diagnostics Holdings Q3 2026 Results: Net Loss of $1.73M, Loss Widens

Cardio Diagnostics Holdings, Inc. reported a net loss of $5,021,957 for the nine months ended September 30, 2026, compared to $5,032,799 in the prior year period. Revenue remains minimal at $11,630 for the nine-month period, while the company maintains a cash balance of $3,942,882 following a common stock issuance that raised approximately $3.69 million.

Key figure
Net loss $1.73M
4:46 PM ET 8-K
Shareholder Meeting

Cardio Diagnostics Holdings Shareholder Meeting

Cardio Diagnostics Holdings held its 2026 Annual Meeting of Stockholders on September 18, 2026, where shareholders elected seven directors and ratified Prager Metis CPAs LLC as the independent auditor. Additionally, stockholders approved the potential future issuance of common stock exceeding 20% of outstanding shares in non-public transactions, as required by Nasdaq Listing Rule 5635(d).

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.